[Testing of Eprazinone, a new drug with antiobstructive effect on the respiratory tract].
D000402:Airway Obstruction / Q000188:drug therapy* / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D009921:Metaproterenol / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D010919:Placebos; D011427:Propiophenones / Q000494:pharmacology / Q000627:therapeutic use*; D012119:Respiration / Q000187:drug effects; D012129:Respiratory Function Tests
D001993:Bronchodilator Agents; D010879:Piperazines; D010919:Placebos; D011427:Propiophenones; D009921:Metaproterenol
Prüfung von Eprazinone, einer neuen Substanz mit antiobstruktiver Wirkung auf die Atemwege